Related Experiment Video
Updated: Feb 3, 2026

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
Published on: March 10, 2023
Emerging functions of DNA transposases and oncogenic mutators in childhood cancer development
Anton G Henssen1,2,3, Alex Kentsis4,5
1Department of Pediatric Oncology/Hematology, Charité-Universitätsmedizin, Berlin, Germany.
Abstract:
Our understanding of the molecular pathogenesis of childhood cancers has advanced substantially, but their fundamental causes remain poorly understood. Recently, multiple mechanisms of DNA damage and repair have been associated with mutations observed in human cancers. Here, we review the physiologic functions and oncogenic activities of transposable genetic elements. In particular, we focus on the recent studies implicating DNA transposases RAG1/2 and PGBD5 as oncogenic mutators that promote genomic rearrangements in childhood leukemias and solid tumors. We outline future studies that will be needed to define the contributions of transposons to mutational processes that become dysregulated in cancer cells. In addition, we discuss translational approaches, including synthetic lethal strategies, for identifying and developing improved clinical therapies to target oncogenic transposons and transposases.
Insights
Transposable genetic elements, specifically DNA transposases RAG1/2 and PGBD5, act as oncogenic mutators. These elements promote genomic rearrangements in childhood cancers, highlighting new therapeutic targets.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- Childhood cancer pathogenesis is complex, with fundamental causes often unclear.
- DNA damage and repair mechanisms are increasingly linked to cancer mutations.
- Transposable genetic elements (transposons) have recognized physiological roles and potential oncogenic activities.
Purpose of the Study:
- To review the oncogenic roles of transposable genetic elements, focusing on DNA transposases RAG1/2 and PGBD5.
- To highlight their implication in promoting genomic rearrangements in pediatric leukemias and solid tumors.
- To outline future research directions and translational therapeutic strategies.
Main Methods:
- Literature review of recent studies on transposable elements and cancer.
- Focus on the role of RAG1/2 and PGBD5 as oncogenic mutators.
- Discussion of potential therapeutic strategies, including synthetic lethality.
Main Results:
- DNA transposases RAG1/2 and PGBD5 are implicated as oncogenic mutators.
- These transposases promote genomic rearrangements in various childhood cancers.
- Transposons contribute to dysregulated mutational processes in cancer cells.
Conclusions:
- Transposons and their associated enzymes play a significant role in childhood cancer development.
- Further research is needed to fully understand transposon contributions to cancer mutational processes.
- Targeting oncogenic transposons and transposases offers potential for novel clinical therapies.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
Mutations
Piaget's Theory of Cognitive Development from Childhood into Adulthood
Schemata: Building Blocks of Knowledge
DNA-only Transposons
The donor site from where the transposon is excised is either degraded or...
Fruit Development, Structure, and Function

